What is the median survival time post-lung transplant for AATD patients?
Click to see answer
6.4 years.
Click to see question
What is the median survival time post-lung transplant for AATD patients?
6.4 years.
What was the median post-lung transplant survival for AATD patients?
6.4 years.
How did the survival outcomes compare between single and double lung transplants?
Double lung transplant recipients had significantly better survival outcomes than single lung transplant recipients.
What role does AAT play in lung function and inflammation?
AAT inhibits neutrophil serine proteases and reduces inflammation.
What was the finding regarding FEV1 rates in AATD patients after lung transplantation?
Similar rates of decline in FEV1 for single lung transplants but faster decline for double lung transplants.
How many AATD patients underwent lung transplantation between March 1992 and September 2019?
2,213 patients.
What were some pre- and post-transplant characteristics evaluated for their association with mortality?
Age, gender, BMI, pre-transplant oxygen requirement, mPAP, ECMO presence, type of lung transplant, CMV and EBV mismatch, ischemia time, re-intubation, length of hospitalization, and treatment for acute rejection.
How does the post-lung transplant mortality of AATD patients compare to usual COPD patients?
AATD patients have increased post-LT mortality due to infections and liver disease.
What is the estimated prevalence of AATD in the United States?
1 in 5,097 individuals.
What was the median survival for single and double lung transplants?
4.4 years for single LT and 7.7 years for double LT.
How does the risk of infections in AATD patients compare to usual COPD patients?
AATD patients have a higher risk of infections (HR 1.21, CI 1.04 – 1.42, p = 0.02).
What is the survival advantage of double lung transplants compared to single lung transplants for AATD patients?
There is a significant survival advantage for double lung transplants.
What is the primary objective of the study on lung transplantation in AATD patients?
To describe disease-specific outcomes in patients with alpha-1 antitrypsin deficiency (AATD) following lung transplantation.
What was the median age of patients at the time of listing for lung transplantation?
51 years.
What percentage of AATD patients received a lung transplant in the study?
66% of the 1556 AATD patients had died by the time of data analysis.
How does the 10-year survival rate for AATD patients compare to usual COPD patients?
23% for AATD compared to 43% for usual COPD.
What was the median post-transplantation survival for AATD patients with double lung transplants?
7.7 years.
What is being investigated regarding AAT infusion therapy post-lung transplant?
Its impact on pulmonary function tests and bronchiolitis obliteration syndrome.
What was the initial survival trend observed in AATD patients post-lung transplant?
Worse initial survival followed by improved outcomes around the 4-year mark.
What percentage of AATD patients experienced treatment for rejection within the first year of transplantation?
39%.
What were the common etiologies leading to death for AATD and COPD patients?
Both AATD and COPD share the same eight most common etiologies.
What was the median time spent on the lung transplant waitlist?
263 days.
How does survival compare between double lung transplant and single lung transplant in AATD patients?
Double lung transplant has a median survival of 7.7 years compared to 4.4 years for single lung transplant.
What were the survival rates for AATD patients at 1, 5, and 10 years post-transplant?
82%, 56%, and 34%, respectively.
What does the biphasic course in survival rates indicate?
It indicates non-proportional hazards that may be unadjusted for potential unobserved or unavailable factors.
What is the median survival time for AATD lung transplant recipients?
6.4 years (IQR 1.8 – 12.2 years).
What does the Cox proportional hazard ratio indicate about age in AATD patients?
Age has a hazard ratio of 5.68, indicating a significant impact on survival.
What were the 1-, 5-, and 10-year survival rates for AATD patients post-lung transplant?
82%, 56%, and 34%, respectively.
What was the median waiting-list time for lung transplantation?
263 days, reduced to 158 days after the lung allocation score was instituted.
What were the most common causes of mortality among AATD recipients?
Infection (23%), graft failure (23%), and respiratory failure (16%).
What is the 1-year survival rate for usual COPD recipients of lung transplants?
86%.
What factor had a significant hazard ratio affecting survival in AATD patients?
CMV mismatch (present) with a hazard ratio of 1.57.
What statistical model was used to evaluate mortality after lung transplantation (LT)?
Cox proportional hazard model.
What factors were found to impact post-lung transplant mortality in AATD patients?
Increasing age, presence of CMV mismatch, reintubation prior to discharge, and requiring treatment for rejection within one year.
How does the median survival of AATD single lung transplant recipients compare to double lung transplant recipients?
AATD single LT had a median survival of 4.4 years, which is lower than the 7.7 years for double LT.
What was the median survival for COPD patients who underwent double lung transplants?
6.6 years.
What was observed about the survival rates of AATD lung transplant recipients compared to usual COPD recipients?
AATD LT recipients had a higher failure rate initially, which improved over time and surpassed usual COPD.
What is the leading cause of post-lung transplant death for AATD patients?
Sepsis and infections.
What factors impacted post-lung transplant mortality?
Increasing age, presence of CMV mismatch, reintubation prior to discharge, and requiring treatment for rejection within one year.
What was the 10-year survival percentage for COPD patients who underwent single lung transplants?
21%.
What factors were associated with increased post-lung transplant mortality in AATD patients?
Increasing age, CMV mismatch, and requiring treatment for rejection within the first year.
What was the 5-year survival percentage for AATD patients who underwent double lung transplants?
62%.
What was the median age at the time of transplant for AATD patients?
51.9 years.
What is the significance of neutrophil elastase activity in AATD patients post-lung transplant?
Unopposed neutrophil elastase activity may contribute to lung injury and susceptibility to infections.
What was the 10-year survival rate for AATD lung transplant recipients in the study?
34%.
What notable difference in mortality was observed for liver failure between AATD and usual COPD patients?
Liver failure accounted for 2% in AATD compared to 0.4% in usual COPD (HR 5.67, p < 0.001).